Industry News
United Bioresearch appointed Australian distributor for Abiocode
United Bioresearch has announced its appointment as the Australian distributor for Californian-based Abiocode. [ + ]
Biotron releases more data from HCV trial
Biotron has presented some pharmacokinetic data from its phase IIa trial of BIT225 in HCV, showing no evidence of drug resistance growth. [ + ]
pSivida partner gets new PDUFA date for Iluvien
The US FDA will decide by 17 October whether to approve pSivida (ASX:PVA) licensee Alimera’s NDA for Iluvien in diabetic macular edema. [ + ]
Concern over plan to remove or limit patent extensions
AusBiotech has made a submission in response to the Pharmaceutical Patent Review’s (PPR) Draft Report, stating its disappointment at the options provided under recommendation 5 to remove or reduce Australia’s patent extension provisions. [ + ]
Screening for Alzheimer’s disease
The development of a blood test for the early detection of Alzheimer’s disease takes a step forward. [ + ]
Study reveals ancient microbial feasting
The first-ever snapshot of primitive organisms eating each other has been found in ancient fossils examined by a team of scientists at The University of Western Australia (UWA). [ + ]
High-speed discovery helps measure greenhouse gases from space
Scientists have discovered how to measure greenhouse gases 200,000 times faster as the result of research by an award-winning PhD student from The University of Western Australia (UWA) and a US team. [ + ]
CPR launches ligand binding assay service for large molecules
Clinical research company CPR Pharma Services has launched a new laboratory in Adelaide to provide a ligand binding assay service for biomarkers, monoclonal antibodies, biosimilars and biologics in early- and late-phase clinical trials. [ + ]
Alchemia wins US patent for drug discovery platform
Alchemia (ASX:ACL) has secured US patent protection for its VAST small molecule drug discovery platform through to 2025. [ + ]
Schubert steps onto Garvan board
Dr John Schubert has been elected Chairman of the Board at the Garvan. [ + ]
Imugene wins Chinese Linguet patent
Imugene (ASX:IMU) has secured its second patent from an Asian market protecting the use of its Linguet drug-delivery technology for formulations of drugs to prevent bone loss. [ + ]
Qiagen acquires Ingenuity Systems
Qiagen has announced the acquisition of Ingenuity Systems, a provider of software solutions that efficiently and accurately analyse and interpret the biological meaning of genomic data. [ + ]
ResMed posts record profit for March quarter
ResMed (ASX:RMD) grew its March-quarter profit by 31% and revenue by 10%, thanks to strong gains in the Americas region. [ + ]
GTG settles another DNA patent suit
Genetic Technologies (ASX:GTG) has announced a second settlement agreement in as many days for patent infringement lawsuits it filed in the US. [ + ]
Australian-made malaria vaccine to enter human trials
Australian researchers have developed the first malaria vaccine that can be tailored to combat the many variants of malaria that exist around the world. Human trials of the vaccine will begin next year. [ + ]
